Discrimination power of mGPS and IMDC in predicting survival outcomes based on Uno’s concordance statistic
| OS | PFS | |||
| Estimate | SE* | Estimate | SE* | |
| mGPS | 0.6312 | 0.0435 | 0.5752 | 0.0385 |
| IMDC | 0.6102 | 0.0397 | 0.5533 | 0.0347 |
*SEs are calculated using 5000 perturbation samples.
IMDC, International Metastatic Renal Cell Carcinoma Database Consortium; mGPS, modified Glasgow Prognostic Score; OS, overall survival; PFS, progression-free survival.